| it's more than a result
PremierTox offers a vast array of testing options, all at clinically relevant cut-offs to arm you with the information you need to make adequate prescribing decisions.
Individual drugs or drug groups may be added to our proprietary panels or selected for independent analysis to ensure targeted quantification of drugs and their metabolites for clinical diagnosis and compliance monitoring.
PremierTox qualtitative testing utilizes leading edge sensitivity for the identification of targeted drugs and drug classes. PremierTox qualitative analysis provides clinically relevant drug detection for enhanced compliance monitoring and improved patient outcomes.
Managing your patients' compliance with prescribed treatment is complex. Effective monitoring requires testing that's flexible to the individual needs of the patient, while precisely detecting PremierTox AutoReflex, is a recommended methodology for medically necessary compliance monitoring by most insurance companies, including Medicare.
The PremierTox Oral Fluid Quantitative Assay is a highly sophisticated test for drugs and metabolites in saliva. Our proprietary analytical methodology employs some of the most sensitive detection cut-offs in the industry to support your therapeutic drug monitoring needs when urine testing is not an available option.
Individual drugs or drug groups may be added to our proprietary panels or selected for independent analysis to ensure targeted quantification of drugs and their metabolites for clinical diagnosis and compliance monitoring.
Proven Accuracy at low clinical cutoffs: results you can trust
Proprietary methodology at a reduced cost
Rapid turn around times that speed results back to your practice:
screen results available same business day
final confirmation results available next business day
Clinical and toxicology expertise in real-time to help inform your treatment decisions
